comparemela.com

Latest Breaking News On - New york heart association functional class - Page 1 : comparemela.com

Liquidia Corporation: FDA Still Reviewing NDA to Add PH-ILD Indication for Treprostinil Inhalation Powder

On January 25, 2024, the day following the proposed PDUFA goal date, Liquidia Corporation announced the FDA was still reviewing the NDA for pulmonary hypertension with interstitial lung disease for treprostinil inhalation powder (Yutrepia).

Standard Therapy Plus Empagliflozin Did Not Affect LV Global Longitudinal Strain in HFrEF

A study has found no improvement in LV contractile reserve in patients with HFrEF that receive empagliflozin plus standard therapy.

Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q1 2022 Results - Earnings Call Transcript

Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2022 Earnings Conference Call May 4, 2022, 04:30 PM ET Company Participants Diane Weiser - SVP of Corporate Communications and IR Robert.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.